{"id":"https://openalex.org/W7222918487","doi":"https://doi.org/10.1093/neuonc/noag238","title":"Biomarker-guided treatment strategies for patients with gliomas in clinical practice","display_name":"Biomarker-guided treatment strategies for patients with gliomas in clinical practice","alternate_titles":[],"publication_year":2026,"publication_date":"2026-10-19","ids":{"openalex":"https://openalex.org/W7222918487","doi":"https://doi.org/10.1093/neuonc/noag238","pmid":"https://pubmed.ncbi.nlm.nih.gov/42895284"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/noag238","doi":"https://doi.org/10.1093/neuonc/noag238","is_oa":false,"landing_page_url":"https://doi.org/10.1093/neuonc/noag238","pdf_url":null,"source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7222918487"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077744058","display_name":"\u00c9milie Le Rhun","orcid":"https://orcid.org/0000-0002-9408-3278","observed_orcids":["https://orcid.org/0000-0002-9408-3278"]},"institutions":[{"id":"https://openalex.org/I202697423","display_name":"University of Zurich","ror":"https://ror.org/02crff812","country_code":"CH","type":"education","lineage":["https://openalex.org/I202697423"]},{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Emilie Le Rhun","raw_affiliation_strings":["University Hospital and University of Zurich Department of Medical Oncology and Hematology, , Zurich, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital and University of Zurich Department of Medical Oncology and Hematology, , Zurich, Switzerland","institution_ids":["https://openalex.org/I202697423","https://openalex.org/I4210100468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020324479","display_name":"Ingo K. Mellinghoff","orcid":"https://orcid.org/0000-0002-4347-8149","observed_orcids":["https://orcid.org/0000-0002-4347-8149"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ingo K Mellinghoff","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center Department of Neurology, , New York, NY, NY10065, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center Department of Neurology, , New York, NY, NY10065, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017041986","display_name":"Tobias Wei\u00df","orcid":"https://orcid.org/0000-0002-5533-9429","observed_orcids":["https://orcid.org/0000-0002-5533-9429"]},"institutions":[{"id":"https://openalex.org/I202697423","display_name":"University of Zurich","ror":"https://ror.org/02crff812","country_code":"CH","type":"education","lineage":["https://openalex.org/I202697423"]},{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tobias Weiss","raw_affiliation_strings":["University Hospital and University of Zurich Department of Neurology, , Zurich, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital and University of Zurich Department of Neurology, , Zurich, Switzerland","institution_ids":["https://openalex.org/I202697423","https://openalex.org/I4210100468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045726522","display_name":"Marian Christoph Neidert","orcid":"https://orcid.org/0000-0003-2828-4706","observed_orcids":["https://orcid.org/0000-0003-2828-4706"]},"institutions":[{"id":"https://openalex.org/I4210094062","display_name":"University Medical Center of the Johannes Gutenberg University Mainz","ror":"https://ror.org/00q1fsf04","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210094062"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marian C Neidert","raw_affiliation_strings":["University Hospital Mainz Department of Neurosurgery, , Mainz, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital Mainz Department of Neurosurgery, , Mainz, Germany","institution_ids":["https://openalex.org/I4210094062"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5154861998","display_name":"Wolfgang Wick","orcid":"https://orcid.org/0000-0002-6171-634X","observed_orcids":["https://orcid.org/0000-0002-6171-634X"]},"institutions":[{"id":"https://openalex.org/I17937529","display_name":"German Cancer Research Center","ror":"https://ror.org/04cdgtt98","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I17937529"]},{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]},{"id":"https://openalex.org/I2802164966","display_name":"University Hospital Heidelberg","ror":"https://ror.org/013czdx64","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2802164966"]},{"id":"https://openalex.org/I4391767962","display_name":"Deutsches Konsortium f\u00fcr Translationale Krebsforschung","ror":"https://ror.org/02pqn3g31","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4391767962","https://openalex.org/I4405256427"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wolfgang Wick","raw_affiliation_strings":["Clinical Cooperation Unit Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK) , Heidelberg, Germany","University Hospital Heidelberg, Heidelberg University Department of Neurology and European Center for Neurooncology (EZN), , Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Cooperation Unit Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK) , Heidelberg, Germany","institution_ids":["https://openalex.org/I17937529","https://openalex.org/I4391767962"]},{"raw_affiliation_string":"University Hospital Heidelberg, Heidelberg University Department of Neurology and European Center for Neurooncology (EZN), , Heidelberg, Germany","institution_ids":["https://openalex.org/I223822909","https://openalex.org/I2802164966"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5136663268","display_name":"Michael Weller","orcid":"https://orcid.org/0000-0002-1748-174X","observed_orcids":["https://orcid.org/0000-0002-1748-174X"]},"institutions":[{"id":"https://openalex.org/I202697423","display_name":"University of Zurich","ror":"https://ror.org/02crff812","country_code":"CH","type":"education","lineage":["https://openalex.org/I202697423"]},{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Weller","raw_affiliation_strings":["University Hospital and University of Zurich Department of Neurology, , Zurich, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital and University of Zurich Department of Neurology, , Zurich, Switzerland","institution_ids":["https://openalex.org/I202697423","https://openalex.org/I4210100468"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5077744058"],"corresponding_institution_ids":["https://openalex.org/I202697423","https://openalex.org/I4210100468"],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"noag238","last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioma","display_name":"glioma","score":0.8500000238418579},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.8389999866485596},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.9039999842643738},{"id":"https://openalex.org/keywords/biomarker-enrichment","display_name":"biomarker enrichment","score":0.6880000233650208},{"id":"https://openalex.org/keywords/idh-mutation","display_name":"IDH mutation","score":0.8550000190734863},{"id":"https://openalex.org/keywords/vorasidenib","display_name":"vorasidenib","score":0.984000027179718},{"id":"https://openalex.org/keywords/braf-mutation","display_name":"BRAF mutation","score":0.6349999904632568},{"id":"https://openalex.org/keywords/ependymoma","display_name":"ependymoma","score":0.9279999732971191},{"id":"https://openalex.org/keywords/clinical-trial-design","display_name":"clinical trial design","score":0.8040000200271606},{"id":"https://openalex.org/keywords/pharmacodynamic-endpoints","display_name":"pharmacodynamic endpoints","score":0.7760000228881836}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6363999843597412},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.5282999873161316},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5001999735832214},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4699000120162964},{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.41920000314712524},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4025999903678894},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.3944000005722046},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38999998569488525},{"id":"https://openalex.org/C2777150147","wikidata":"https://www.wikidata.org/wiki/Q261968","display_name":"Isocitrate dehydrogenase","level":3,"score":0.3682999908924103},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.3571999967098236},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.35679998993873596},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3553999960422516},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.3499999940395355},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3467999994754791},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.3465000092983246},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3151000142097473},{"id":"https://openalex.org/C2780775027","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Salvage therapy","level":3,"score":0.31150001287460327},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3098999857902527},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.30000001192092896},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2797999978065491},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.2718000113964081},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.25589999556541443},{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.2556999921798706},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2540000081062317},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.2533999979496002}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/neuonc/noag238","doi":"https://doi.org/10.1093/neuonc/noag238","is_oa":false,"landing_page_url":"https://doi.org/10.1093/neuonc/noag238","pdf_url":null,"source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmid:42895284","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42895284","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7140225918","https://openalex.org/W2626614537","https://openalex.org/W4387435524","https://openalex.org/W2973085389","https://openalex.org/W7203628393","https://openalex.org/W4403572987","https://openalex.org/W4308917777","https://openalex.org/W7160281516","https://openalex.org/W4402417477","https://openalex.org/W4402692449"],"abstract_inverted_index":{"Targeted":[0],"therapy":[1,32,100,178],"has":[2,16,94],"made":[3],"important":[4],"contributions":[5],"to":[6,38,49,161],"improving":[7],"outcomes":[8],"for":[9,91,98,169,180,214],"patients":[10,24,137,172,215],"with":[11,25,138,173,216],"many":[12],"solid":[13],"tumors,":[14,66],"but":[15],"had":[17],"only":[18],"limited":[19],"activity":[20],"so":[21,45],"far":[22,46],"in":[23,33,58,64,136,199],"gliomas,":[26,93],"notably":[27],"glioblastoma.":[28],"Failure":[29],"of":[30,40,78,101,110,119,171,210],"targeted":[31,99,177],"glioblastoma":[34],"is":[35],"likely":[36],"due":[37],"redundance":[39],"oncogenic":[41],"pathway":[42],"activation":[43],"and":[44,53,115,194],"the":[47,86,96,120,204,208],"inability":[48],"identify":[50],"suitable":[51],"targets":[52,166],"apply":[54],"biomarker-based":[55],"enrichment":[56],"strategies":[57],"clinical":[59,75,185],"trial":[60,186],"designs.":[61],"In":[62],"contrast,":[63],"non-glioblastoma":[65],"there":[67],"are":[68,203],"promising":[69],"developments":[70],"which":[71],"have":[72,182],"already":[73],"changed":[74,95],"practice:":[76],"inhibition":[77],"mutant":[79],"isocitrate":[80],"dehydrogenase":[81],"(IDH)":[82],"exemplified":[83],"by":[84],"vorasidenib,":[85],"first":[87],"approved":[88],"drug":[89],"specifically":[90],"IDH-mutant":[92],"landscape":[97],"WHO":[102],"grade":[103],"2":[104],"gliomas.":[105,143,174,217],"Furthermore,":[106],"dordaviprone,":[107],"an":[108,116],"antagonist":[109],"dopamine":[111],"receptor":[112,149,156],"D2/3":[113],"(DRD2/3)":[114],"allosteric":[117],"agonist":[118],"mitochondrial":[121,124],"protease":[122],"caseinolytic":[123],"matrix":[125],"peptidase":[126],"proteolytic":[127],"subunit":[128],"(ClpP),":[129],"emerges":[130],"as":[131,164],"a":[132],"potentially":[133],"active":[134,212],"agent":[135],"recurrent":[139],"K27M-mutant":[140],"diffuse":[141],"midline":[142],"Finally,":[144],"BRAF":[145],"mutations,":[146],"neurotrophic":[147],"tyrosine":[148],"kinase":[150],"(":[151],"r":[152],"fibroblast":[153],"growth":[154],"factor":[155],"(FGFR)":[157],"gene":[158],"fusions":[159],"continue":[160],"raise":[162],"interest":[163],"therapeutic":[165],"at":[167],"least":[168],"subsets":[170],"Almost":[175],"no":[176],"approaches":[179],"ependymomas":[181],"emerged.":[183],"Improved":[184],"designs":[187],"including":[188],"shared":[189],"control":[190],"arms":[191],"early":[192],"on":[193],"using":[195],"pharmacodynamic":[196],"endpoints":[197],"ideally":[198],"enriched":[200],"patient":[201],"populations":[202],"path":[205],"forward":[206],"towards":[207],"identification":[209],"further":[211],"treatments":[213]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7222918487","counts_by_year":[],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2026-10-20T00:00:00"}
